This is your blog intro text.
2023 Annual Meeting brings name change, hosts 200 NCBIO became the NC Life Sciences Organization at its 2023 Annual Meeting held Oct. 4 at the NC Biotechnology Center, and approximately 200 member representatives enjoyed networking and engaging panel discussions. Novartis’ Emily Chee... Continue Reading
2022 NCBIO Year in Review From the NCBIO President | Laura Gunter I look back on the past 12 months of NCBIO’s work, and what stands out most to me is how much time and effort we have put into looking forward. The year was perhaps most notable for the... Continue Reading
The NC Biosciences Organization, known as NCBIO, is changing its name to the NC Life Sciences Organization, or NCLifeSci for short. NCLifeSci is the trade association for North Carolina’s life sciences industry. The organization’s Board of Directors made the name change as part of... Continue Reading
At the 2023 NCLifeSci Annual Dinner, Sen. Paul Newton, co-chair of the Life Sciences Caucus in the NC General Assembly, shared his insights on leadership, culture and complacency in organizations. Key takeaways from Newton’s talk were prioritize long-term thinking when investing in... Continue Reading
William “Bill” Monteith has been selected by the NC Life Sciences Organization as the new program director for the organization’s Biomanufacturers Forum. Over the course of his 42-year career, Monteith has overseen the construction of and served as site head of at least six... Continue Reading
2023 Taylor Scholarship recipients Lila Bradshaw and Stephanie Alston at the NCLifeSci Annual Meeting Five community college students have been awarded the prestigious Samuel M. Taylor Memorial Life Sciences Scholarship, providing up to $3,000 per student to offset the cost of tuition, fees... Continue Reading
Life Sciences Caucus chairs field questions at Legislative Forum NCBIO President Laura Gunter, Sen. Mike Woodard, Rep. Robert Rieves, Rep. Donna White and Joe Lanier, principal at Milestone Strategies Don’t expect a state budget anytime soon, encourage... Continue Reading
A new study estimates that there would be 237 fewer FDA approvals of new medicines over the next decade and 1.1 million lost jobs if proposals to expand government-mandated drug pricing policies are implemented. The policies include allowing Medicare to set prices for specific drugs five years... Continue Reading
NCBIO held its 2022 Legislative Reception on Wednesday, June 22, at the North Carolina Museum of History in Raleigh. The event was well attended by NCBIO members who were joined by a number of state senators, including Life Science Caucus Co-Chair Sen. Mike Woodard and Sens. Lisa Barnes,... Continue Reading
The rarest day on the calendar is the one that does not even occur in every year: February 29. In 2008, this was designated as Rare Disease Day and since then, the last day of February has been an opportunity to draw attention to, honor and support people living with these... Continue Reading
Where things stand with the TRIPS waiver It’s been a while since we’ve talked about what’s going on at the WTO. Here’s the latest news — and why extending the waiver of COVID-19 vaccine IP is still a bad idea. The status: The World Trade Organization... Continue Reading
Expanding COVID IP waiver would harm small, medium enterprises, CSBA says Every member of the Council of State Bioscience Associations signed a letter to President Joe Biden expressing serious concerns with the proposed expansion of IP protections for COVID technology. In June, the... Continue Reading
